Abbvie Symposium
Title: CLEAR horizons
Open Horizons: Up-to-Date Treatment Options for Inflammatory Skin Diseases
Room: Room A (Concord Ballroom) – 5F (main tower)
PROGRAM:
16:50 – 16:55 Opening
Eung Ho Choi
16:55 – 17:15 Bench to Bedside – AbbVie Development History
Annette Schwarz
17:15 – 17:45 Biologics for Psoriasis and other diseases – IL-23
Melinda Gooderham
17:45 – 18:15 JAKis for AD and other diseases
Melinda Gooderham
18:15 – 18:20 Closing
Eung Ho Choi
Maruho Symposium
Title: The Birth of a Novel Treatment for Itching with IL-31RA Antibody
Room: Room B (Eminence Hall) – 5F (south tower)
PROGRAM:
Importance of IL-31 signaling in pruritic skin diseases
Chair: Kenji Kabashima
Speaker: Bernhard Homey
Characterization of sensory nerves transmitting itch during skin barrier impairment and inflammation
Chair: Lisa A. Beck
Speaker: Takaharu Okada
Understanding the role of IL31 as a target for atopic dermatitis
Chair: Norito Katoh
Speaker: Gil Yosipovitch
Japan Blood Products Organization Symposium
Title: Dermatomyositis
Room: Room A (Concord Ballroom) – 5F (main tower)
Boxed breakfast provided
PROGRAM:
Chair: Manabu Fujimoto
Single cell analysis and the role of cytokines in dermatomyositis
Victoria P. Werth
Novel autoantigens in cancer associated dermatomyositis
David Fiorentino
Otsuka Pharmaceutical Symposium
Title: Pathophysiology of Atopic Dermatitis
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed breakfast provided
PROGRAM:
Chairs: Takeshi Nakahara, Hiroyuki Murota
PDE4 inhibition by difamilast regulates filaggrin and loricrin expression via keratinocyte proline-rich protein in human keratinocytes.
Gaku Tsuji
Basophils in the pathogenesis of atopic dermatitis
Hajime Karasuyama
Kaken Pharmaceutical Symposium
Title: New Findings on Terbinafine-resistant Dermatophytosis – Epidemiology, resistance mechanisms, and prevention methods.
Room: Room C (Nishiki) – 4F (south tower)
Boxed breakfast provided
PROGRAM:
Chair: Kazutoshi Harada
New findings on terbinafine-resistant dermatophytosis: Epidemiology, resistance mechanisms, and prevention methods
Rui Kano
Taisho Pharmaceutical Symposium
Title: Visualization of vascular network in the skin and brain enables the understanding of stem cell niche -Cross-talk system between “vasculature” and “hair cycle/minoxidil/skin homeostasis”
Room: Room D (Ohgi) 4F (south tower)
Boxed breakfast provided
PROGRAM:
Visualization of vascular network in the skin and brain enables the understanding of stem cell niche -Cross-talk system between “vasculature” and “hair cycle/minoxidil/skin homeostasis”
Chair: Manabu Ohyama
Speaker: Ken-ichi Mizutani
AMRYT Symposium
Title: Epidermolysis Bullosa – Concepts for Change
Room: Room F (Harmony) – 44F (main tower)
Boxed breakfast provided
PROGRAM:
Faculty: John McGrath, Dedee Murrell, Mauricio Torres-Pradilla
07:00 Opening Remarks – The Complexity of EB
John McGrath
07:05 EB Wounds – A Fundamental Priority
Mauricio Torres
07:10 Approaching a New Era for Patients with EB
John McGrath
07:20 Defining and Measuring Patient Outcomes
Dedee Murrell
07:35 Translating Clinical Studies into Clinical Practice
Mauricio Torres
07:45 Panel Discussion and Audience Questions, Closing Remarks
John McGrath
UCB Medical Symposium
Title: Understanding Hidradenitis Suppurativa: an Educational Symposium
Room: Room A (Concord Ballroom) – 5F (main tower)
Boxed lunch provided
PROGRAM:
Chairs: Kenji Kabashima, and Nicole Ward
Introducing HS: what does psoriatic disease tell us about the drivers of inflammation?
Stevan Shaw
Understanding HS: what have we uncovered about its complex pathophysiology?
James Krueger
Managing HS: where are we now and where do we aim to be?
Kenzo Takahashi
Taiho Pharmaceutical/Janssen Pharmaceutical K. K. Symposium
Title: Pathophysiology of Psoriasis and the Role of IL-23
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed lunch provided
PROGRAM:
Chair: Yoshihide Asano
Speaker: Tetsuya Honda
Bristol Myers Squibb Symposium
Title: A New Pathway for Psoriasis Treatment
Room: Room C (Nishiki) – 4F (south tower)
Boxed lunch provided
PROGRAM:
Chair: Akiharu Kubo
Positioning of Deucravacitinib in Psoriasis Treatment
Speaker: Yukie Yamaguchi
Chair: Ryuhei Okuyama
Differentiation of SOTYKTU from pan-JAKis – mechanisms to basic science
Speaker: Johann Gudjonsson
Pfizer Symposium
Title: JAK and Other Kinase Inhibitors in Dermatology: Dawn of a New Therapeutic Era
Room: Room D (Ohgi) 4F (south tower)
Boxed lunch provided
PROGRAM:
Welcome and Introductions
Melinda Gooderham
Kinase Pathways: Gateway to Understanding Immuno-Inflammatory Dermatological Diseases
Melinda Gooderham
The Therapeutic Potential of a New Drug Class: Kinase inhibitors in Dermatology
Thierry Passeron
Panel Discussion / Q&A
All
Sulwhasoo (Amorepacific) Symposium
Title: Skin Epigenetics
Room:Room E (Moonlight) – 43F (main tower)
Boxed lunch provided
PROGRAM:
Chair: Jin Ho Chung
Epigenetic Landscape of Skin Aging
Sewon Kang
Advanced epigenetic regulation for skin anti-aging
Kyu-Han Kim
CHANEL Fragrance & Beauty Symposium
Title: Senescence: The Global Approach to Skin Aging
Room: Room F (Harmony) – 44F (main tower)
Boxed lunch provided
PROGRAM:
Chairs: Youcef Ben Khalifa and Florian Gruber
Analytic Imaging of Senescence – Induced Changes in Lipid and Carbohydrate Metabolism
Florian Gruber
Impact of Cellular Senescence in Aging Pigmentation
Hee Young Kang
Cosmetic Application: CHANEL Natural ingredients Regulating Senescence Pathways for Unmatched Anti-aging Benefits of our Products
Sandra Forestier
Galderma Symposium
Title: Targeting itch and beyond: IL-31, a central neuroimmune mediator in atopic dermatitis and prurigo nodularis
Room: Room G (Takao) – 42F (main tower)
Boxed lunch provided
PROGRAM:
12:05–12:08 Chair’s welcome and introduction
Lisa Beck
12:08–12:20 The torment of itch: Understanding the invisible symptom
Lisa Beck
12:20–12:35 IL-31 signaling: Neuroimmune mediation in itch, inflammation and epithelial structure
Bernhard Homey
12:35–12:50 The unique role of IL-31: Uncovering the pathophysiology of atopic dermatitis and prurigo nodularis
Lam C. (Alex) Tsoi
12:50–13:05 Panel discussion and close
All; facilitated by Prof. Lisa Beck
Sanofi Symposium
Title: Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis: Research breakthroughs leading to therapeutic innovations for patients with atopic dermatitis
Room: Room B (Eminence Hall) – 5F (south tower)
PROGRAM:
Chair: Masayuki Amagai
Role of Type 2 Inflammation in Chronic Inflammatory Diseases
Constance Katelaris
Importance of Skin Barrier Dysfunction in Driving AD Pathophysiology
Lisa A. Beck
Connection Between Type 2 Inflammation and the Neuroimmune Mechanisms and Pruritus in AD
Tilo Biedermann
Janssen Symposium
Title: Unlocking the IL-23 pathway: looking back to move forward for psoriasis management
Room: Room A (Concord Ballroom) – 5F (main tower)
Boxed lunch provided
PROGRAM:
12:05 Welcome and introduction: Akimichi Morita
Objective: Welcome attendees and introduce programme
12:10 Past perspectives are key: IL-23 as the key cytokine in psoriatic disease
Dan Cua
Objective: Discuss the journey of IL-23, from its discovery to the impact it has had on the clinic.
12:20 The guiding light: disease memory and early intervention in psoriasis
Andreas Pinter
Objective: Provide the latest insights on how early intervention by targeting the Th17/IL-23 pathway could maintain long-term disease control.
12:30 Diverging threads: small changes, big implications?
James G. Krueger
Objective: Provide new insights into the mechanisms of action of IL-23 inhibitors and discuss how these mechanisms can potentially affect their therapeutic profiles of these drugs.
12:40 Looking forward: panel discussion and Q&A
All faculty; moderated by Prof. Morita
13:00 Closing remarks
Prof. Morita
Nippon Boehringer Ingelheim Symposium
Title: Latest research on pustular skin diseases
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed lunch provided
PROGRAM:
Chair: Masashi Akiyama
The Role of IL-36 in Pustular Psoriasis: What Have We Learnt from Genetic Studies?
Francesca Capon
The Role of Neutrophils in Skin Diseases
Tatsuyoshi Kawamura
No 7 Beauty Company Symposium
Title: Matrix-derived Cosmetic Peptides (matrikines) for the Rejuvenation of Photoaged Skin
Room: Room C (Nishiki) – 4F (south tower)
Boxed lunch provided
PROGRAM:
12.05 – 12.10 Welcome
Mike Bell
12.10-12.25 Predicting matrix-derived peptides using in silico machine learning approaches
Objective: How protein susceptibility algorithms and machine learning approaches can be used to predict breakdown of extracellular matrix proteins and the release of putative bioactive peptides called ’matrikines’.
Mike Sherratt
12.25 – 12.40 Novel peptides identified using machine learning approaches show wide-ranging activity in cultured human dermal fibroblasts
Objective: Evidence that novel ‘matrikine’ peptides identified using machine learning approaches show dermal remodelling activity in vitro; utilising a range of techniques including omics.
Alexander Eckersley
12.40-12.55 A novel peptide-blend has potential as a topical anti-ageing cosmeceutical; Evidence from a short-term patch test protocol for skin remodelling
Objective: Evidence that a novel peptide-blend first identified using machine learning shows promise as a topical anti-ageing cosmeceutical, based on a validated short-term patch test protocol to assess skin remodelling in photoaged skin using immunohistochemical markers and transcriptomic characterisation.
Rachel Watson
Shiseido Symposium
Title: Skin Beauty Provided by Healthy Blood and Lymphatic Vascular Systems
Room: Room D (Ohgi) 4F (south tower)
Boxed lunch provided
PROGRAM:
Chair: Kenji Kabashima
The Importance of Blood Vessels and Lymphatic Vessels for Skin Health, Aging and Beauty
Michael Detmar
Holistic Beauty by Promoting Blood/Lymphatic Vessel Function in Skin
Kentaro Kajiya
LEO Pharma Symposium
Title: Updated Information About the Roles of IL-13 in Atopic Dermatitis
Room: Room E (Moonlight) – 43F (main tower)
Boxed lunch provided
PROGRAM:
Chairs: Takeshi Nakahara, and Chih-ho Hong
The Roles of IL-13 in Atopic Dermatitis
Kenji Izuhara
Torii Pharmaceutical Company, LTD. Symposium
Title: Understanding the Pathogenesis of Atopic Dermatitis
Room: Room F (Harmony) – 44F (main tower)
Boxed lunch provided
PROGRAM:
Chair: Norito Katoh
Itch of Atopic Dermatitis and Janus Kinase: Chasing the Itch Jackpot
Takashi Hashimoto
Impact of Staphylococcal Agr in Atopic Dermatitis and Systemic Infection
Yumi Matsuoka-Nakamura
Eli Lilly Symposium
Title: Explore Our Future from Investigative Research in Alopecia Areata, Atopic Dermatitis and Psoriasis
Room: Room A (Concord Ballroom) – 5F (main tower)
PROGRAM:
Chairs: Manabu Ohyama and Chris Griffiths
Eli Lilly’s R&D strategy in Dermatology
Lotus Mallbris
Latest Insights on the Pathogenesis and Treatment of Alopecia Areata
Ohsang Kwon
Unraveling the Heterogeneity of Atopic Dermatitis: “A Closer Look at Longitudinal Course”
Raj Chovatiya
RWE for Clinical Decision Making in Psoriasis
Andreas Pinter
Nov division, TOKIWA Pharmaceutical Co., Ltd Symposium
Title: New Technology Opens the Future of Dermatology
Room: Room A (Concord Ballroom) – 5F (main tower)
Boxed breakfast provided
PROGRAM:
Chairs: Shinichi Sato and Manabu Fujimoto
What can we learn from Fli1-deficient mice, new animal models of systemic sclerosis?
Yoshihide Asano
How to utilize genomics in dermatology
Yukinori Okada
Amgen Symposium
Title: TBA
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed breakfast provided
PROGRAM:
Chairs: Daisuke Tsuruta,and Hiroyuki Murota
The possible role of psoriatic skin inflammation for the development of systemic organ dysfunction and osteoporosis
Yu Sawada
Mitochondrial metabolism in psoriatic T cells
Rei Watanabe
Sato Pharmaceutical/Eisai Co Symposium
Title: Fosravuconazole, an Oral Antifungal Agent for the Treatment of Onychomycosis: Basic Characteristics and Clinical Effects
Room: Room C (Nishiki) – 4F (south tower)
Boxed breakfast provided
PROGRAM:
Chairs: Yoshiki Miyachi, and Nikolas Haass
Mycological characteristics of the causative agents of onychomycosis
Takashi Sugita
Key points for achieving complete cure in the treatment of onychomycosis
Taisuke Ito
Nobelpharma Symposium
Title: Therapeutic Effects of Topical Sirolimus on Skin Lesions in Tuberous Sclerosis: Including clinical collaboration
Room: Room D (Ohgi) 4F (south tower)
Boxed breakfast provided
PROGRAM:
Chair: Masatoshi Jinnin
Speaker: Sei-ichiro Motegi
Incyte Symposium
Title: Vitiligo Pathophysiology and Emerging Treatments
Room: Room E (Moonlight) – 43F (main tower)
PROGRAM:
Welcome and introduction
Jim Lee
Vitiligo pathophysiology and emerging treatments
Mehdi Rashighi Firoozabadi
Panel Discussion and Audience Q & A
Novartis Pharma K.K. Symposium
Title: Reimagining Immuno-dermatology
Room: Room A (Concord Ballroom) – 5F (main tower)
PROGRAM:
Reimaging Urticaria
Chair: Kenji Kabashima
Speaker: Marcus Maurer
Reimagining Melanoma-2023
Chair: Russell Hall
Speaker: Victoria Atkinson
Reimagining Memory of Skin Inflammation
Chair: Yoshiki Tokura
Speaker: Liv Eidsmo
UCB Symposium
Title: Spotlight on Psoriasis: New Perspectives on Therapy and Pathology
Room: Room A (Concord Ballroom) – 5F (main tower)
Boxed lunch provided
PROGRAM:
Chairs: Akimichi Morita, and Christopher Griffiths
Painting a Picture: The Therapeutic Landscape of Psoriasis
Yayoi Tada
Straight Up: How Does the ‘Cytokine Cocktail’ Drive the Progression of Psoriasis?
James Krueger
Janssen Pharmaceutical/Taiho Pharmaceutical Symposium
Title: Characteristics of Palmoplantar Pustulosis
Room: Room B (Eminence Hall) – 5F (south tower)
Boxed lunch provided
PROGRAM:
Chairs: Kazumitsu Sugiura, and Riichiro Abe
Characteristics of Japanese patients with palmoplantar pustulosis
Masamoto Murakami
Clinical characteristics and treatment status of palmoplantar pustulosis
Mitsumasa Kishimoto
Mitsubishi Tanabe Pharma/Teikoku Seiyaku Symposium
Title: Itch Caused by Common Skin Disease
Room: Room C (Nishiki) – 4F (south tower)
Boxed lunch provided
PROGRAM:
Chair: Shinichi Sato
Mechanism and therapeutics of itch in atopic dermatitis
Saeko Nakajima
Pruritus in Urticaria Management
Naoko Inomata
The Estée Lauder Companies Inc. Symposium
Title: Skin Barrier Function and Approaches for Improving Innate Hydration of Skin
Room: Room D (Ohgi) 4F (south tower)
Boxed lunch provided
PROGRAM:
Chair: Kenji Kabashima
Moisturize your skin by the skin innate hydration
Teruki Dainichi
New moisturizing ingredient for improving skin’s innate hydration – Rice Power™ #11α
Yuichi Miyoshi
In vitro/in vivo proven superior hydration benefits of Rice Power™ #11α containing formulations
Richard Cao
SUN Pharma Symposium
Title: How to Apply Genetic Information to Autoimmune Research
Room: Room E (Moonlight) – 43F (main tower)
Boxed lunch provided
PROGRAM:
Chair: Shinji Shimada
How to Apply Genetic Information to Autoimmune Research
Speaker: Kazuhiko Yamamoto
Procter & Gamble Symposium
Title: A Novel Approach in Understanding Skin Leveraging Spatial Biology
Room: Room F (Harmony) – 44F (main tower)
Boxed lunch provided
PROGRAM:
In vivo skin imaging: towards non-invasive skin biopsy
Gyohei Egawa
Spatial Analysis via Single-Cell RNA Sequencing: Galactomyces Ferment Filtrate’s Efficacy on Human Epidermis
Satoshi Nakamizo